malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid by Lone, Abdul G et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
malT knockout mutation invokes a stringent type gene-expression 
profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid
Abdul G Lone1, Vincent Deslandes2,3, John HE Nash4,5, Mario Jacques2,3 and 
Janet I MacInnes*1
Address: 1Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada, 2Groupe de 
Recherche sur les Maladies Infectieuses du Porc, Université de Montréal, St-Hyacinthe, Québec J2S 7C6, Canada, 3Centre de Recherche en 
Infectiologie Porcine, Université de Montréal, St-Hyacinthe, Québec J2S 7C6, Canada, 4Institute for Biological Sciences, National Research Council 
of Canada, Ottawa, Ontario K1A 0R6, Canada and 5Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, 
Ottawa, Ontario K1A 0K9, Canada
Email: Abdul G Lone - alone@uoguelph.ca; Vincent Deslandes - vincent.deslandes@umontreal.ca; John HE Nash - john_nash@phad-aspc.gc.ca; 
Mario Jacques - mario.jacques@umontreal.ca; Janet I MacInnes* - macinnes@uoguelph.ca
* Corresponding author    
Abstract
Background:  Actinobacillus pleuropneumoniae causes contagious pleuropneumonia, an
economically important disease of commercially reared pigs throughout the world. To cause this
disease, A. pleuropneumoniae must rapidly overcome porcine pulmonary innate immune defenses.
Since bronchoalveolar fluid (BALF) contains many of the innate immune and other components
found in the lungs, we examined the gene expression of a virulent serovar 1 strain of A.
pleuropneumoniae after exposure to concentrated BALF for 30 min.
Results:  In reverse transcription PCR differential display (RT-PCR DD) experiments, A.
pleuropneumoniae CM5 exposed to BALF up-regulated, among other genes, a gene predicted to
encode LamB, an outer-membrane transport protein of the maltose regulon. To determine the
role of the lamB and other genes of the maltose regulon in the pathogenesis of A. pleuropneumoniae,
knockout mutations were created in the lamB  and  malT  genes, the latter being the positive
transcriptional regulator of the maltose regulon. Relative to the lamB mutant and the wild type, the
malT mutant had a significant (P < 0.05) decrease in growth rate and an increased sensitivity to fresh
porcine serum and high concentrations (more than 0.5 M) of sodium chloride. In DNA microarray
experiments, the BALF-exposed malT mutant exhibited a gene-expression profile resembling that
of a stringent type gene-expression profile seen in bacteria facing amino acid or carbon starvation.
Genes encoding proteins for protein synthesis, energy metabolism, and DNA replication were
down-regulated, while genes involved in stringent response (e.g., relA), amino acid and nucleotide
biosynthesis, biofilm formation, DNA transformation, and stress response were up-regulated.
Conclusion: These results suggest that MalT may be involved in protection against some stressors
and in the transport of one or more essential nutrients in BALF. Moreover, if MalT is directly or
indirectly linked to the stringent response, an important global mechanism of bacterial persistence
and virulence in many bacterial pathogens, it might play a role in A. pleuropneumoniae pathogenesis.
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Background
A. pleuropneumoniae causes contagious pleuropneumonia
in pigs. The disease can occur in acute, sub-acute, or
chronic form [1]. The acute form is characterized by fibri-
nohemorrhagic pneumonia and the sub-acute and
chronic forms by pleuritis with localized necrotizing
lesions. The severity and the spread of the disease depend
upon the serovar and dose of the strain, and in large meas-
ure, upon the immune status of the herd [2].
A. pleuropneumoniae is well adapted to survive and repli-
cate in the host respiratory tract. Its survival and replica-
tion requires the expression of genes encoding proteins
that protect the bacterium from the host immune
response and help it to acquire nutrients. Although RTX
(repeats in toxin) toxins, lipopolysaccharide, capsule, and
various amino acid and iron transport systems of the bac-
terium are essential to cause acute disease [3], it is not
known how the organism survives in the face of non-cel-
lular innate immune components that form the first line
of defence in the lungs [4]. To identify A. pleuropneumoniae
genes that are expressed in a medium that mimics, at least
in part, the alveolar surface environment of the lungs, we
incubated the bacterium in concentrated porcine bron-
choalveolar lavage fluid (BALF). In addition to innate
immune components, such as collectins, defensins, lys-
ozyme, lactoferrin, and cathelicidin [4], BALF contains
surfactant, surfactant-associated proteins, dissolved min-
erals, and other substances functioning in antioxidation,
lipid metabolism, and tissue repair and proliferation in
the lungs [5]. Thus, genes expressed by A. pleuropneumo-
niae in porcine BALF may be important for survival and
pathogenesis of the organism.
In RT-PCR DD experiments, A. pleuropneumoniae CM5
exposed to BALF for 30 min differentially expressed a
number of genes, including seemingly a lamB homolog.
Consistent with this finding, an earlier study had also
reported that A. pleuropneumoniae expresses a maltose-
inducible, LamB-like outer membrane protein in the
host[6]. In E. coli and other gram-negative bacteria, lamB
encodes an outer membrane transport protein involved in
the transport and metabolism of maltose and maltodex-
trins. The E. coli maltose regulon is comprised of at least
ten genes whose transcription is positively regulated by
MalT in the presence of maltotriose derived from either
imported maltodextrins or endogenous glycogen [7].
In addition to maltose and maltodextrin transport and
metabolism, the genes of the maltose regulon have been
associated, in ways less well understood, with virulence in
bacteria. For example, MalF, an inner membrane maltose
and maltodextrin transport protein, and MalQ, a dextrinyl
transferase, have been associated with the expression of
cholera toxin and toxin-co-regulated pilus in Vibrio chol-
erae [8], as has been LamB with cytopathic effect in enter-
opathogenic E. coli [9], and adhesion in enteroinvasive E.
coli [10] and Aeromonas veronii [11]. Mutants of the malE
and malT (transporter) genes in group A Streptococcus are
attenuated in their ability to grow in human saliva and to
metabolize α glucans and are significantly impaired in
their ability to colonize the mouse oropharynx [12,13].
To elucidate the role of the predicted maltose regulon in
A. pleuropneumoniae, malT  and lamB  knockout mutants
were constructed and characterized phenotypically. Since
MalT is a regulatory protein, the effect of its knockout on
the bacterial gene expression level was also determined
using DNA microarrays.
Results
Expression of maltose-regulon genes by the wild-type A. 
pleuropneumoniae CM5 in BALF
Several differentially expressed genes in A. pleuropneumo-
niae CM5 exposed to BALF for 30 min at 37°C were first
presumptively identified by RT-PCR DD studies. These
included genes encoding protein synthesis and hypothet-
ical proteins (APL_068, APL_0363, and APL_0367), in
addition to a cell surface protein, LamB (Figure 1).
Homologs (>99% DNA identity) of the 3 hypothetical
proteins are present in all the serotypes of A. pleuropneu-
moniae sequenced so far, suggesting that they might have
a role in persistence or pathogenesis, but their levels of
expression were not confirmed by real-time PCR or other
more direct methods. The level of expression of the lamB
gene was estimated by real-time PCR analysis to be 3.3-
fold higher in BALF- than in BHI-exposed cells (Table 1).
Genes of the maltose regulon that were also up-regulated
(although some at very low levels) in BALF-exposed cells
included malF and malG  (encoding the intrinsic mem-
brane proteins of maltose transport system), malP (malto-
dextrin phophorylase), malQ (amylomaltase) and malK
(the ATP-binding cassette of the maltodextrin transporter;
Table 1). For further study, we constructed lamB and malT
mutants to evaluate the possible role of these genes in the
survival of A. pleuropneumoniae CM5.
Growth curves of the malT and lamB mutants
The malT mutant grew slower than the wild-type organism
in BHI. The growth pattern of the lamB mutant was, how-
ever, similar to that of the wild-type organism (Figure 2).
Effect of acarbose on the growth of the isogenic malT and 
lamB mutants of A. pleuropneumoniae CM5
To assess the effect of the malT knockout mutationon the
functioning of the maltose regulon, the parent strain and
the malT mutant were grown in acarbose-containing BHI
in the presence or absence of maltose. Acarbose is a com-
petitive inhibitor of maltose transport [14]. Because of the
fastidious nutritional requirements of A. pleuropneumo-BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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niae, this experiment was performed in BHI instead of a
chemically defined medium. After 16 h of incubation in
acarbose-containing BHI that was supplemented with
maltose, the wild-type organism reached a significantly
lower OD600 (P < 0.05) than did the malT mutant (Figure
3). In acarbose-containing BHI that was not supple-
mented with maltose, there was again, a significant differ-
ence in the growth of the two strains. The number of wild
type and malT mutant cells was lower in acarbose-contain-
ing BHI than in the BHI containing both maltose and
acarbose; however, this difference was not significant (Fig-
ure 3). The lamB mutant showed a trend similar to that of
the  malT  mutant grown in the acarbose-containing
medium, but the number of lamB mutant cells was lower
than that of the malT mutant; however, this difference was
not significant.
Survival of the malT and lamB mutants
Because LamB is a cell surface protein that is positively
regulated by MalT, we examined the effects of serum and
high concentrations of sodium chloride to better under-
stand the role of these genes in the survival of A. pleurop-
neumoniae. The percent survival of the malT mutant after
incubation at 37°C for 1 h in 90 and 50% porcine serum
was significantly (P < 0.05) lower than the percent sur-
vival of the wild- type strain (Figure 4). There was no sig-
nificant difference in the survival between the wild-type
organism and the lamB mutant in either concentration of
the serum. The number of cells of all the three strains
(wild-type organism, malT and lamB mutants) surviving
in 90% serum was higher than the number of cells surviv-
ing in 50% serum. E. coli DH5α did not survive in either
concentration of serum.
In the maltose-supplemented BHI containing different
concentrations of sodium chloride, the wild type parent,
and the malT and lamB mutants showed a significant (P <
0.05) decrease in cell numbers after 3 h of incubation
(Figure 5). The decrease in the cell number was least in the
wild-type organism and greatest in the malT mutant. In 1
M sodium chloride, the malT mutant decreased in number
from an initial count (prior to the addition of the salt to
Table 1: Differential expression of maltose-regulon genes in BALF-exposed A. pleuropneumoniae CM5
Gene Putative function ΔΔCT ± SD Fold-change*
malE (T) Periplasmic maltose binding protein -2.82 ± 0.51 7.06 (4.95-10.05)
malE (R) 0 ± 0.84 1 (0.55-1.79)
malF (T) Intrinsic membrane protein of maltose transport system -2.79 ± 1.01 6.91 (3.43-13.92)
malF (R) 0 ± 0.39 1 (0.76-1.31)
malG (T) Intrinsic membrane protein of the maltose transport system -2.6 ± 0.40 6.06 (8-4.59)
malG (R) 0 ± 0.40 1(0.76-1.31)
malK (T) ATP-binding protein of the maltodextrin transporter -1.10 ± 0.39 2.14 (1.6-2.8)
malK (R) 0 ± 0.76 1(0.59-1.69)
lamB (T) Maltoporin -1.73 ± 0.46 3.31 (2.41-4.56)
lamB (R) 0 ± 0.35 1(0.78-1.27)
malP (T) Maltodextrin phosphorylase -0.85 ± 0.46 1.80(1.31-2.46)
malP (R) 0 ± 0.79 1(0.58-1.72)
malQ (T) Amylomaltase -0.96 ± 0.48 1.94(1.39-2.71)
malQ (R) 0 ± 0.55 1(0.68-1.46)
malT (T) Transcriptional activator of maltose-regulon genes -0.75 ± 0.32 1.68(1.34-2.09)
malT (R) 0 ± 0.79 1(0.58-1.72)
* Fold change is the fold increase or decrease in the level of expression of a gene in the wild type exposed to BALF (target sample, abbreviated as 
T) relative to the level of expression of the gene in the wild type exposed to BHI (calibrator or reference sample, abbreviated as R), as measured by 
real-time PCR.
Values in the parentheses represent the range in the fold change.
Silver-stained gel comparing A. pleuropneumoniae RT-PCR  DD products in BHI broth (1) and BALF (2) Figure 1
Silver-stained gel comparing A. pleuropneumoniae 
RT-PCR DD products in BHI broth (1) and BALF (2). 
The arrow points to the band representing a differentially 
expressed gene, which based on cloning and sequencing (see 
Methods), appeared to be lamB.BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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the medium) of 107 CFU/ml to a final count (3 h subse-
quent to the addition of the salt to the medium) of 10
CFU/ml. Even at a 2 M salt concentration, the wild-type
organism decreased in number to only 5 log CFU/ml from
approximately the same initial count as that of the malT
mutant. At salt concentrations of 1 M and above, the lamB
mutant showed a decline in cell numbers midway
between those of the numbers shown by the parent strain
and the malT mutant. The wild-type organism, and the
malT and lamB mutants were all susceptible to killing by
high concentrations of sodium chloride, but this killing
was greatest in the malT mutant (Figure 5).
Differential gene expression by the malT mutant in BALF
To understand the basis of the observed phenotypic differ-
ences between the malT mutant and the wild-type organ-
ism, gene expression profiles of the mutant and parent
strains were compared using DNA microarrays. Following
the incubation of the exponentially grown cultures of the
mutant and wild-type organism in fresh BHI at 37°C for
30 min, no significant differences were observed in the
Growth curves of the wild type strain and lamB and malT mutants in BHI broth Figure 2
Growth curves of the wild type strain and lamB and malT mutants in BHI broth.
Overnight growth of the wild type strain and the lamB and malT mutants in acarbose or maltose Figure 3
Overnight growth of the wild type strain and the lamB and malT mutants in acarbose or maltose. The bars with 
same letters on the top do not differ significantly (P < 0.05)BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
Page 5 of 15
(page number not for citation purposes)
gene expression profiles of the two strains even at low
delta values. Incubation in BALF, however, resulted in a
total of 223 genes being differentially expressed in the
malT mutant at a false discovery rate (the percentage of the
differentially expressed genes identified just by chance) of
1%. The differentially expressed genes included 104 up-
regulated and 119 down-regulated genes and 92 of these
encoded hypothetical proteins (Table 2, Additional file 1:
Analyzed microarray data). In general, the genes encoding
proteins involved in energy metabolism and protein bio-
synthesis were down-regulated (Table 3), while as those
involved in amino acid and nucleotide biosynthesis, DNA
transformation, and biofilm formation were up-regulated
(Table 4). The relA gene encoding a stringent response reg-
ulatory protein was also up-regulated in the malT mutant.
Though known as an in vivo-expressed RTX toxin, the
apxIVA gene was up-regulated by the wild-type strain in
BALF [15] and its expression was further increased in
BALF in the malT mutant.
Expression of selected genes representing biological func-
tional categories of interest was also measured by real-
time PCR analysis (Table 5). A good corroboration in the
context of the up- and down-regulation of the genes was
found between the microarray and real-time PCR data.
Discussion
Expression of maltose-regulon genes by BALF-exposed A. 
pleuropneumoniae CM5
After exposure of A. pleuropneumoniae CM5 to BALF for 30
minutes, a gene that appeared to be lamB homologue was
shown to be up-regulated by the organism in RT-PCR DD
experiments (Figure 1). We selected 30 min for incubation
of the organism in BALF, as the medium conditions
should remain fairly constant during this time as might be
seen in the animal during early infection when there is
constant replenishment of alveolar fluid. As shown in
real-time PCR studies, the genes encoding intrinsic mem-
brane transport system proteins (MalF and MalG), malto-
dextrin phosphorylase (MalP), amylomaltase (MalQ),
ATP-binding cassette of the maltodextrin transporter
(MalK) of the maltose regulon were also up-regulated in
BALF, although some at very low levels (Table 1). Com-
parison of gene expression in BALF- and BHI-incubated
cells by DNA microarrays [15] showed that malF and malG
were up-regulated in BALF. However, no differential
expression was seen in malT, malK, malP or malQ genes.
This disparate finding could be because only small quan-
tities of these proteins are required for function, and small
changes in gene expression are difficult to detect. For fur-
ther study, we focused on the lamB and malT genes of the
maltose regulon as LamB is a cell surface protein that lies
at the host-pathogen interface and MalT is a transcrip-
tional regulator that might control the expression of genes
other than those involved in the maltose and maltodex-
trin transport and metabolism.
malT and lamB are the components of a functional 
maltose regulon in A. pleuropneumoniae CM5
All of the strains of A. pleuropneumoniae sequenced so far
possess homologs of the maltose regulon genes malEFG,
malK-lamB-malM, malT and malPQ. As demonstrated by
microarray-based comparative genomic profiling, these
genes are present in the reference strains of all 15 serovars
of A. pleuropneumoniae [16]. It might be noted that mal-
Percent survival of the wild type strain, and the malT and  lamB mutants in porcine serum Figure 4
Percent survival of the wild type strain, and the malT 
and lamB mutants in porcine serum. The percent sur-
vival is the fresh-serum-surviving CFU expressed as the per-
cent of CFU surviving in the heat inactivated serum. The 
strains were incubated in fresh and heat-inactivated serum 
for 1 h. The bars with same letters on the top do not differ 
significantly (P < 0.05)
CFU of the wild type strain, and the malT and lamB mutants  in different NaCl concentrations Figure 5
CFU of the wild type strain, and the malT and lamB 
mutants in different NaCl concentrations. The strains 
were incubated for 3 h in the salt-containing BHI medium. 
Before being exposed to NaCl, the strains were grown in 
maltose-containing BHI. The bars with the same letters on 
the top do not differ significantly (P < 0.05)BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
Page 6 of 15
(page number not for citation purposes)
Table 2: Number of genes expressed differentially* within a functional category by the BALF-exposed malT mutant
Functional category Up-regulated genes Down-regulated genes
Protein biosynthesis 2 7
Amino acid biosynthesis 6 2
Cofactor biosynthesis 4 8
Biofilm formation 4 0
Nucleotide biosynthesis 3 0
Lipid biosynthesis 0 2
Lipid degradation 1 0
Cell envelope biosynthesis 3 10
Cellular processes 5 2
Central intermediary metabolism 0 4
DNA metabolism 3 6
Energy metabolism 7 18
Protein folding and stabilization 2 2
Regulatory proteins 7 2
Transcriptional regulators 0 5
Secretion and trafficking 4 10
Mobile and extra-chromosomal function 2 0
Unclassified and unknowns 51 41
Total 104 119
* Differential expression of a gene in the malT mutant is relative to the level of expression of the gene in the wild-type organism, as measured in 
microarray experiments.
Table 3: Protein-synthesis and energy-metabolism genes expressed differentially* by the BALF-exposed malT mutant
Type of the product encoded by the differentially 
expressed gene
Up-regulated genes Down-regulated genes
Ribosomal proteins and their modifiers rpmE rplQ, rpsQ, rplI, rpmG
tRNA base modifiers queA alaS, truD, trmU,
Transcription and transcription-related factors deaD, rnc, rph, nusA, nusB
Amino acid biosynthetic enzymes trpD, dapA, argD, proC, leuC, ilvH, tyrR aroA, aroB,
Periplasmic nitrate reductase (nap operon) napB, napG, napF, napD, napH
Nitrite reductase (nrf operon) nrfB, nrfC
Dimethyle sulfoxide reducatse (dms operon) dmsA, dmsB
Hydrogenases hyaA, hybB
Amino acid catabolism sdaA, aspA
pyruvate formate-lyase 1-activating enzyme PflA
Glycolysis and gluconeogenesis gpmB, pepC FruK
TCA cycle enzymes sucD, lpdA
Non-glucose hexose-monosaccharide metabolism enzymes mtlD nagZ
Products of central intermediary metabolism ureA, ppx
ATP synthase atpC, atpB
Formate dehydrogenase fdhE
Products involved in fermentation dld, aldA
Regulatory proteins narP, sixA, gntR, cysB, asnC, gcvA, rseA arcA, iclR
Cofactors folA, folP, pdxY, thiH hemB, chuW, lipA, ispA, ddc, dxs, ispE, iscA
* Differential expression of a gene in the malT mutant is relative to the level of expression of the gene in the wild-type organism (reference sample) 
as measured in microarray experiments. For complete gene names and the fold changes in gene expression see Additional file 1: Analyzed 
microarray data.BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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Table 4: Nutrient-acquisition, replication and virulence genes expressed differentially* by the BALF-exposed malT mutant
Type of the product encoded by the differentially expressed 
gene
Up-regulated genes Down-regulated genes
Biofilm-formation proteins pgaA, pgaC, tadF, apfB
Toxin apxIVA
Factors imparting resistance to antimicrobials ostA, ccp
Peptidoglycan and LPS biosynthetic enzymes cpxD, mrdA dacA, murA, mltA, dacB, mreD, fbB1, kdsB, gmhA
Membrane proteins ompP1 ompW, oapB
Amino acid transporters brnQ, sdaC
Carbohydrate transporter mtlA ptsB, rbsD
Iron transport proteins cbiO exbD2, afuB_2, frpB, yfeC, exbB2
Protein/peptide transport proteins dppF
Other cation transporters ptsN
Cell division fic
Lipid transporters glpF
Factors involved in adaptation to unusual environment relA
DNA transformation comEA, comF
DNA degradation proteins xseA
DNA replication, recombination proteins recG, rdgC, recJ xerC, recR, priB, polA, ligA, recA,
Protein-fate proteins htpX, prlC ecfE
Nucleotide metabolism enzymes purC, purD, purT
Phopholipid and fatty acid biosynthesis and degradation enzymes namA accA, fabD
* Differential expression of a gene in the malT mutant is relative to the level of expression of the gene in the wild-type organism (reference sample). 
For complete gene names and the fold changes in gene expression see Additional file 1: Analyzed microarray data.
Table 5: Verification of microarray data by real-time PCR
Gene Putative function ΔΔCT ± SD Fold change by real-time PCR Fold change by microarray1
dmsA (T) Anaerobic dimethyl sulfoxide reductase chain A 
precursor
3.45 ± 1.41 0.091 (0.03-0.24) 0.15
dmsA (R) 0 ± 0.51 1 (0.69-1.42)
dmsB (T) Anaerobic dimethyl sulfoxide reductase chain B 2.54 ± 1.61 0.17 (0.05-0.52) 0.34
dmsB (R) 0 ± 0.46 1 (0.72-1.38)
napB (T) Nitrate reductase cytochrome c-type subunit 2.24 ± 0.41 0.21 (0.15-0.28) 0.17
napB (R) 0 ± 0.49 1 (0.71-1.40)
napF (T) Ferredoxin-type protein NapF 2.24 ± 0.46 0.21 (0.07-0.61) 0.09
napF (R) 0 ± 0.47 1 (0.71-1.39)
napD (T) Putative napD protein 2.39 ± 0.34 0.18 (0.14-0.24) 0.18
napD (R) 0 ± 0.54 1 (0.68-1.46)
ilvH (T) Acetolactate synthase small subunit -2.60 ± 0.36 6.08 (4.68-7.90) 6.14
ilvH (R) 0 ± 0.45 1 (0.70-1.41)
pgaA (T) Biofilm PGA synthesis protein PgaA precursor -2.04 ± 1.08 4.11 (1.94-8.70) 8.18
pgaA (R) 0 ± 0.74 1 (0.59-1.67)
pgaC (T) Biofilm PGA synthesis N-glycosyltransferase 
PgaC
-2.47 ± 0.42 5.54 (4.12-7.45) 6.23
pgaC (R) 0 ± 1.05 1(0.48-1.07)
apxIVA (T) RTX toxin protein -3.01 ± 1.12 8.06 (3.69-17.61) 6.5
apxIVA (R) 0 ± 0.60 1 (0.65-1.52)
relA (T) GTP pyrophosphokinase -0.95 ± 0.42 2.0 (1.44-2.56) 6.30
relA (R) 0 ± 0.59 1(0.66-1.51)
lamB (T)2 Maltoporin 1.03 ± 0.39 0.49 (0.37-0.64) na3
lamB (R) 0 ± 0.23 1 (0.85-1.17)
1Fold change is the fold increase or decrease in the level of expression of a gene in the malT mutant (target sample, abbreviated as T) relative to the 
level of expression of the gene in the wild type (calibrator or reference sample, abbreviated as R) in BALF except for the lamB gene2 whose 
expression was compared in BHI to examine the effect of the malT knockout mutation on the expression of the lamB gene. 3 Not applicable.
Values in the parentheses represent the range in the fold change.BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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tose regulon genes are also present in two other upper res-
piratory tract pathogens, Mannheimia haemolytica and
Haemophilus parasuis. The arrangement of some of these
genes in A. pleuropneumoniae, however, differs from that
found in E. coli. As in E. coli, MalT appears to be a positive
transcriptional regulator of lamB in A. pleuropneumoniae as
demonstrated by a two-fold decrease in the expression of
lamB in the isogenic malT mutant of A. pleuropneumoniae
CM5 in BHI supplemented with maltose (Table 5). This
finding is consistent with an earlier phenotypic study [6]
which reported that A. pleuropneumoniae expresses a
LamB-like outer membrane protein when maltose is
added to BHI agar. Moreover, the A. pleuropneumoniae
MalT and LamB has a high degree of amino acid similarity
with MalT and LamB homologs of a number of other
Gram-negative organisms. Also, MalT has a conserved
DNA-binding (LuxR-like C-terminal containing helix-
turn-helix) motif such as found in the E. coli MalT protein.
To further examine the effect of the malT mutation on the
regulation of the maltose regulon, both the wild-type
organism and the malT mutant were grown in the pres-
ence of acarbose. Acarbose is a pseudo-oligosaccharide
similar in structure to maltotetraose and it is a competitive
inhibitor of maltose transport in E. coli. It can inhibit mal-
tose uptake only if maltose-transport system is first acti-
vated by maltose. Acarbose also inhibits α-amylases and
α-glucosidases and is not degraded by E. coli [14]. In BHI
supplemented with maltose, acarbose reduced the growth
of the wild-type organism as well as that of the malT
mutant (Figure 3). The reduction in the growth might
have been caused either by accumulation of toxic levels of
acarbose by the bacterial cells or by the inhibition of bac-
terial glucosidases by the accumulating acarbose, or both.
The reduction was, however, significantly (P  < 0.05)
greater in the wild-type organism than in the mutant. This
is perhaps due to the increased uptake of acarbose by the
wild-type organism, owing to its higher activation of the
maltose regulon by the intact malT. On the other hand,
the reduction in the growth of the malT mutant could
have been due to the non-specific entry of acarbose into
the bacterial cells.
As A. pleuropneumoniae CM5 is not amenable to comple-
mentation it should be noted that we can not rigorously
exclude the possibility that the phenotype exhibited by
the malT negative strain was affected by some alteration of
another gene that occurred during strain construction, but
this is very unlikely. That said, taken together, the above
findings suggest that A. pleuropneumoniae has a functional
maltose regulon similar to that of E. coli.
malT is required for optimum survival of A. 
pleuropneumoniae CM5 in serum and high 
concentrations of sodium chloride
In comparison with the wild-type A. pleuropneumoniae
CM5 and lamB mutant, the malT mutant had a signifi-
cantly decreased ability to survive following incubation in
fresh porcine serum for 1 h; the wild-type organism, how-
ever, grew in serum to a significantly higher number (Fig-
ure 4). As resistance of A. pleuropneumoniae to killing by
serum is predominantly due to its capsule and LPS
[17,18], the decreased survival of the malT  mutant in
serum could have been due to a change in its cell surface
polysaccharides or to an alteration in its general metabo-
lism as indicated by its slower growth in BHI. Similarly, in
the presence of sodium chloride concentrations of more
than 0.5 M, the malT mutant had a significantly (P < 0.05)
diminished ability to survive in the BHI supplemented
with maltose. This result suggests that MalT-regulated
genes are required for protection against the high concen-
trations of sodium chloride in A. pleuropneumoniae (Figure
5). An association has been shown to exist between the
components of the maltose regulon, stress response, and
hypersomolarity in E. coli [19], but it is not known how
the maltose regulon behaves in the presence of an exoge-
nous activator and high concentrations of the sodium
chloride.
Differential gene expression of the malT mutant in BALF 
resembles the stringent type gene-expression profile
There was no significant difference between the gene
expression profile of the parent strain and the malT
mutant after incubation of the log-phase cultures in fresh
BHI for 30 min. In BALF, however, 223 genes were differ-
entially expressed by the malT mutant (Table 2). The gene
expression profile of the mutant resembled a metabolic
downshift; genes encoding protein synthesis, energy
metabolism, transport of nutrients and DNA replication
were all down-regulated, while those involved in amino
acid and nucleotide biosynthesis, biofilm formation
(prevalent in A. pleuropneumoniae field isolates [20]), DNA
transformation, and the stress response were up-regulated
(Tables 3 and 4). This type of gene-expression response
mimics the gene-expression profile of the stringent
response seen in E. coli and other organisms during nutri-
ent deprivation [21-23].
Carbon starvation in E. coli invokes a global gene expres-
sion response, resulting in the down-regulation of the
genes encoding proteins for the growth and replication of
the organism and the up-regulation of the genes encoding
proteins for the biosynthesis of amino acids, alternate
sigma factors, biofilm components [24], as well as pro-
teins of unknown function [25]. During amino acid star-
vation, the ratio of uncharged to charged tRNA increases,
resulting in ribosome stalling at the A-site of the 50SBMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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ribosomal subunit. The stalling of the ribosome results in
the activation of ribosome-bound RelA. RelA, a synthase
and SpoT, a hydrolase with a weak synthase activity, syn-
thesize pppGpp (guanosine 3'-diphosphate,5'-triphos-
phate) and ppGpp (guanosine 3', 5'-bispyrophosphate)
which in turn invoke a global gene expression response
including down-regulation of rRNA synthesis, such as
seen in the stringent response to nutrient starvation [24].
The increased expression of relA and the changes in the
overall gene expression profile of the malT  mutant in
BALF closely resembled the stringent-response gene-
expression profile in other bacteria, including E. coli. Con-
sistent with the notion of a stringent response having a
role in A. pleuropneumoniae, all the major stringent
response regulatory genes including relA, spoT and dksA
(DnaK suppressor protein) are present in the genome of
this pathogen. A malT knockout mutation in A. pleurop-
neumoniae  could result in a stringent response because
MalTis linked, directly or indirectly, to the regulation of
the stringent response genes, or because it regulates the
uptake of nutrient(s) in addition to maltose and malto-
dextrins. The latter assumption could explain the up-regu-
lation of the lamB gene in BALF as a secondary response to
the activation or the up-regulation of MalT for the acqui-
sition of nutrients. The slower growth of the malT mutant
and its increased sensitivity to the biological stressors
could also be explained by changes in cell surface mole-
cules that result from the inability of the mutant to
acquire unknown essential nutrient(s). By balancing
nutrient availability with ribosome synthesis through the
stringent response, bacteria can control replication, enter
into a persistence mode of life, or express virulence fac-
tors, depending upon the type of bacteria [26-29].
Conclusion
Taken together, our data suggest that A. pleuropneumoniae
CM5 has a functional maltose regulon similar to that
found in E. coli. Although it is likely that these genes have
a role in acquisition of nutrients in saliva and in the
oropharynx where maltodextrins would be predicted to
be found, these studies suggest that the maltose regulon
could also play a significant role once the organism enters
the lungs. Further, the slower growth rate and increased
salt and serum sensitivity of the malT mutant versus lamB
mutant suggests that MalT has a role beyond that of mal-
tose and maltodextrin metabolism in A. pleuropneumoniae.
This is perhaps due to the involvement of the MalT in the
transport or processing of some essential nutrient(s). This
assumption is further supported by the expression of the
stringent type transcript profile in the malT  mutant in
BALF. MalT could also be directly or indirectly linked to
the stringent response without being involved in the
transport of the essential nutrient(s); however, this
remains to be proven. The presence of the maltose-regu-
lon genes in all serovars of A. pleuropneumoniae and in
related pathogens such as Mannheimia haemolytica and
Haemophilus parasuis provides further circumstantial evi-
dence that carbohydrate metabolism mediated by the
maltose regulon might play a role in the persistence, if not
the pathogenesis of some respiratory tract pathogens.
Methods
Bacterial strains and media
A. pleuropneumoniae CM5 [30], and E. coli strains β2155
[31] and DH5α (Clontech, CA, USA) were used in this
study (Tables 6 and 7). A. pleuropneumoniae CM5 was
grown either in brain heart infusion (BHI; Becton, Dickin-
son and Company, Sparks, MD, USA) or Mueller-Hinton
(MH; Becton, Dickinson and Company) medium, supple-
mented with 0.01% (wt/vol) β-nicotinamide adenine
dinucleotide (NAD) as required. Transconjugation
medium consisted of MH broth with 20% (wt/vol)
sucrose, 10% equine serum (wt/vol), and 0.01% NAD
(wt/vol). E. coli strains were routinely cultured in Luria-
Bertani (LB) medium, but in the case of E. coli β2155, the
medium was always supplemented with 1 mM diami-
nopimelic acid (DAP; Sigma-Aldrich, St. Louis, MO,
USA). As required, chloramphenicol was also added at the
rate of either 5.0 or 2.5 μg/ml.
Collection and concentration of bronchoalveolar lavage 
fluid
BALF was collected from ten high-health status pigs of
approximately 15 kg in body weight. After euthanizing the
pigs, the lungs of the individual animals were lavaged
with 100 ml of PBS (phosphate-buffered saline), and the
lung washings were collected and centrifuged to remove
cell debris. The contents of the washings were then con-
centrated with a 5 kDa molecular weight cut off ultra-cen-
trifugal filter device, Vivacell 70 (Vivascience Ltd.,
Stonehouse, GL, UK), which reduced the volume of the
washings to 1/20th that of their total initial volume. The
concentrated BALF was sterilized by filtration through a
0.22 μm membrane filter (Pall Corporation, Ann Arbor,
MI, USA) and kept at -80°C for long-term storage. Mole-
cules less than 5 kDa in molecular weight were not con-
centrated by this method; nevertheless, the fluid still
contained these substances in the concentrations found
before ultrafiltration.
Reverse-transcription PCR differential display
The RT-PCR DD method described by McClelland et al.
[32] was adapted to identify the differentially expressed
genes of A. pleuropneumoniae CM5 in BALF. Briefly, the
organism was grown to an OD600 of 0.7 in BHI at 37°C,
harvested by centrifugation, and an approximately 107
colony forming units (CFU) were suspended in either
concentrated BALF or fresh BHI. After incubation of the
cell suspensions at 37°C for 30 min, the bacteria were har-BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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vested by centrifugation and immediately subjected to
RNA extraction.
RNA was extracted with Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and quantified using RNA 6000 Nano
LabChip chips read in a Bioanalyzer 2100 instrument
(Agilent Technologies, Santa Clara, CA, USA). The RNA
was treated with Turbo RNA-free DNase (Ambion Inc.,
Austin, TX, USA) according to the manufacturer's instruc-
tions.
A total of 0.5 μg of RNA and 85 different combinations
(Table 8) of arbitrary random primers (GenHunter Corp.,
Nashville, Tennessee, USA) (Table 9) were used to synthe-
size cDNA with Moloney Murine Leukemia Virus reverse
transcriptase (M-MLV reverse transcriptase; Invitrogen).
Reverse transcriptase-negative controls were run with each
of the transcription reaction.
One microlitre of the reverse-transcription reaction mix-
ture was used as a template to amplify the cDNA under
relaxed PCR conditions. The same primer pairs were used
in both the template cDNA synthesis and the random PCR
-amplification of the template cDNA. The 20-μl PCR reac-
tion mixtures contained 1.5 μM of each of the forward
and reverse primers, 2.0 μl of 10 × PCR buffer, 200 μM of
dNTP mixture, 4.0 mM MgCl2, and 2.5 U of Taq DNA
polymerase (New England Biolabs, Pickering, ON, Can-
ada). The PCR thermal profile included an initial random
primer annealing and extension steps (denaturation 94°C
for 5 min; primer annealing at 39°C for 5 min; and strand
extension at 72°C for 3 min) followed by a 40-cycle PCR
(denaturation 95°C for 2 min; primer annealing at 39°C
for 2 min; and strand extension at 72°C for 1 min) with a
final amplification step of 10 min at 72°C. PCR products
of the same primer pair were run side by side on 7% poly-
acrylamide gels and silver stained, as described elsewhere
[33], to visualize the bands representing differentially
expressed genes (Figure 1). Bands representing differen-
tially expressed genes were scratched with a 25 gauge nee-
dle to harvest DNA. The DNA on the pointed end of the
needle was dissolved in a 10 μl of PCR-grade water for 5
Table 6: Bacterial strains, plasmids and primers used in the construction of the malT mutant
Bacterial strains, plasmids or primers Characteristic or sequence Source or Remark
E. coli DH5a F-φ80lacZΔM15Δ(lacZYA-rgF)U169 deoR recA1 
endA1 hsdR17(rk -, mk +) supE44 thi-1 gyrA96 
relA1 λ-
Clonetech
E. coli β2155 thrB1004pro thi hsdS lacZΔM15 (F'lacZΔM15lacIq 
traD36 proA+ proB+) Δdap::erm(Ermr)recA::RP4-2-
tet(Tcr)Mu- km(Kmr)λpir
Reference no. 28
E. coli DH5α-pTOPOPCR-malT DH5α harboring pCR4-TOPO containing malT of 
A. pleuropneumiae CM5
This work
E. coli DH5α- pTopoMC DH5a harboring pCR4-TOPO containing 
ΔmalT::cat
This work
E. coli DH5α-pEMOC2M DH5a harboring pEMOC2 containing ΔmalT::cat This work
A. pleuropneumoniae MalT negative mutant of A.T h i s  w o r k
CM5 3ΔmalT pleuropneumonaie CM5
pCR4-TOPO A linearized plasmid for cloning PCR product Invitrogen
pEMOC2 A conjugation vector based on pBluesript SK with 
mobRP4 and Cmr
Reference no. 31
pTOPOPCR-malT pCR4-TOPO containing malT of A. 
pleuropneumiae CM5
This work
pTopoMC pCR4-TOPO containing ΔmalT::cat This work
pEMOC2M harboring pEMOC2 containing ΔmalT::cat This work
malT-L
malT-R
ATGCAAGCAACATTTTCAAGA
TTAGCTATACCCCATCATTCTCAA
Primers for amplification of the malT gene of A
pleuropneumoniae CM5
stopupmalT-L TTAGTTAGTTACGAGCTTTTTCACAC
CGTTT
Primers for generation of a linearized plasmid 
containing a deletion of 900 bp in its malT gene 
cloned in pTOPOPCR-malT.
stopupmalT-R TAACTAACTAATGGGAATGGCATCATTTAG
A
pnmalT-L TCATCTGCAGATGCAAGCAACATTTT
CAAGA
Primers for amplication of the ΔmalT::cat and the 
insertion of the PstI and NotI sites into the PCR 
product.
pnmalT-R ACAATACAGCGGCCGCTTAGCTATACCCC
ATCATTCTCAA
cat-L CGGTGCCCTGAATGAACT Primers for the PCR
cat-R AAGCTTCGACGAATTTCTGC amplification of omlA-P driven cat gene of 
pEMOC2BMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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min. This solution of DNA served as a template for a PCR
reaction in which the same protocol and the same primers
were used as in the differential display PCR that generated
the band. The amplified DNA was run on agarose gels and
stained with ethidium bromide to visualize the bands for
excision. The DNA from the excised bands was purified
using QIAquick Gel Extraction Kits (Qiagen Inc., Missis-
sauga, ON, Canada), and the purified PCR products were
cloned into the pCR4-TOPO (TOPO TA Cloning Kit, Inv-
itrogen), according to the manufacturer's instructions.
The inserts were sequenced by dye terminator cycle
sequencing (DNA Sequencing Facility, College of Biologi-
cal Sciences, University of Guelph, Guelph, ON) and com-
pared with the annotated genome sequences of A.
pleuropneumoniae  using Blastx available at http://
blast.ncbi.nlm.nih.gov/Blast.cgi to identify the complete
genes.
Construction of the malT knockout mutant
Based on the genome sequence of A. pleuropneumoniae
serovar 1 strain 4074, primers were designed to amplify
the entire malT gene (nucleotides 2118860 to 2121577).
The  malT  PCR product was purified and cloned into
Table 7: Bacterial strains, plasmids and primers used in the construction of the lamB mutant
Bacterial strains, plasmids or primers* Characteristic or sequence Source or Remark
E. coli DH5α-pTOPOFL DH5α harboring pCR4-TOPO containing lamB 
of A. pleuropneumia e CM5
This work
E. coli DH5α-TOPOΔFLcat DH5a harboring pCR4-TOPO containing 
ΔlamB::cat
This work
E. coli DH5Δ-pEMOC2-ΔlamB DH5Δharboring pEMOC2 containing ΔlamB::cat This work
A. pleuropneumoniae CM5 ΔlamB LamB negative mutant of A. pleuropneumoniae 
CM5
This work
pTOPOFL pCR4-TOPO containing lamB of A. 
pleuropneumiae CM5
This work
TOPOΔFLcat pCR4-TOPO containing ΔlamB::cat This work
pEMOC2-ΔlamB pEMOC2 containing ΔlamB::cat This work
CrosslamB-L
CrosslamB-R
GGTGGCGTAAAAGTAGGAGAT
TGGTCATTATCCACCACCAA
Primers for the PCR amplification of the lamB 
gene of A. pleuropneumoniae CM5
stopuplamB-L TTAGTTAGTTACAATATTTTCAACC
CCTGCAC
Primers for the PCR generation of a linearized 
plasmid containing a deletion of 400 bp in the lamB 
gene cloned in pTOPOPCR-lamB
stopuplamB-R TAACTAACTAATCACGCACAAGGTTC
AAAAG
PstcrosslamB-L
NotcrosslamB-R
TCATCTGCAGGGTGGCGTAAAAGT
AGGAGAT
ACAATACAGCGGCCGCTGGTCATTATCC
ACCACCAA
Primer sequences for the PCR amplication of the 
ΔlamB::cat and the insertion of the PsTI and NotI 
sites into the PCR product
* The genotype and the source of E. coli DH5α and the pEMOC2 and pCR4-TOPO plasmids are given in Table 6.
Table 8: Arbitrary random primer pair combinations used in RT-
PCR DD
AP17/AP18 AP17/AP19 AP17/AP20 AP17/AP21 AP17/AP21
AP17/AP21 AP17/AP22 AP17/AP23 AP17/AP24 AP17/AP24
AP17/AP24 AP18/AP18 AP18/AP19 AP18/AP19 AP18/AP20
AP18/AP20 AP18/AP21 AP18/AP21 AP18/AP22 AP18/AP22
AP18/AP23 AP18/AP23 AP18/AP24 AP19/AP18 AP19/AP20
AP19/AP21 AP19/AP22 AP19/AP23 AP19/AP23 AP19/AP24
AP20/AP18 AP20/AP21 AP20/AP22 AP20/AP23 AP20/AP24
AP21/AP24 AP21/AP18 AP21/AP22 AP21/AP23 AP22/AP18
AP22/AP23 AP22/AP24 AP23/AP18 AP23/AP24 AP24/AP18
AP41/AP18 AP41/AP42 AP41/AP43 AP41/AP44 AP41/AP45
AP41/AP46 AP41/AP47 AP41/AP48 AP42/AP18 AP42/AP43
AP42/AP44 AP42/AP45 AP42/AP46 AP42/AP46 AP42/AP47
AP43/AP18 AP43/AP44 AP43/AP45 AP43/AP46 AP43/AP47
AP43/AP48 AP43/AP48 AP44/AP18 AP44/AP45 AP44/AP46
AP44/AP47 AP44/AP48 AP45/AP18 AP45/AP46 AP45/AP46
AP45/AP47 AP45/AP48 AP46/AP18 AP46/AP47 AP46/AP48
AP47/AP18 AP47/AP48 AP47/AP48 AP47/AP48 AP48/AP18
Table 9: Sequences of the arbitrary random primers used in RT-
PCR DD
Arbitrary random primer Sequence
AP17 AAGCTTACCAGGT
AP18 AAGCTTAGAGGCA
AP19 AAGCTTATCGCTC
AP20 AAGCTTGTTGTGC
AP21 AAGCTTTCTCTGG
AP22 AAGCTTTTGATCC
AP23 AAGCTTGGCTATG
AP24 AAGCTTCACTAGC
AP41 AAGCTTACGGGGT
AP42 AAGCTTTGCACCG
AP43 AAGCTTGAAGCGG
AP44 AAGCTTCTCCGGA
AP45 AAGCTTGGCTGAC
AP46 AAGCTTCGGTCCT
AP47 AAGCTTATGCCCG
AP48 AAGCTTGCGGTGABMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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pCR4-TOPO. The resultant plasmid was used as the tem-
plate in a PCR reaction to produce a linearized plasmid
with a deletion of the central 838 bp (bp 922 to bp 1760)
of the malT gene. The amplicon was generated using Phu-
sion Taq DNA polymerase (New England Biolabs), a high
fidelity DNA polymerase, and the primers that annealed
in back to back manner leaving a central 900 bp region of
the plasmid malT between them. Following the gel purifi-
cation of the PCR product, the omlA-P promoter driven
chloramphenicol acetyl transferase gene (cat), obtained
by PCR amplification of pEMOC2 [34] was blunt-end
ligated with the linear plasmid. The resultant circular plas-
mid with the cat insertion in the malT was designated as
pTopoMC. The ΔmalT::cat  fragment of pTopoMC was
then PCR amplified with forward and reverse primers con-
taining  NotI and PstI sites, respectively. The ΔmalT::cat
PCR amplicon was gel purified, digested with NotI and
PstI, and cloned into pEMOC2. The resultant plasmid,
named pEMOC2M, was electroporated into E. coli β2155.
pEMOC2M was mobilized from E. coli β2155 into A. pleu-
ropneumoniae CM5 using a modification of the filter mat-
ing technique described by Oswald et al. [35]. Briefly,
overnight cultures of E. coli β2155/pEMOC2M (grown on
LB agar containing 25 μg/ml chloramphenicol), and A.
pleuropneumoniae CM5 (grown on BHI agar) were washed
with 2 ml of TNM buffer (1 mM Tris-HCl, pH 7.2; 10 mM
MgSO4; 100 mM NaCl). The OD600 of both the donor and
the recipient strains was adjusted to 1 by adding TNM
buffer. A 100 μl volume of the donor and 10 μl of the
recipient strains were mixed by inversion, and the mixture
was centrifuged to pellet the cells, which were washed and
then resuspended in 1 ml of fresh TNM buffer. A 50 μl vol-
ume of the suspension was spotted onto a 0.45 μm nitro-
cellulose filter (Pall Corporation) placed onto the BHI
agar plate containing DAP and MgSO4 (10 mM). After
incubation at 37°C for 6 h in an atmosphere of 5% CO2,
the filter was washed with 5 ml of BHI broth. The cells
were harvested by centrifugation and re-suspended in 0.5
ml of BHI broth. After 10-fold serial dilution of the cell
suspension, 50 μl of cells from each of the dilution was
plated onto BHI agar plates containing chloramphenicol
(5 μg/ml). After 24 h of incubation at 37°C, the individ-
ual colonies appearing on the agar plates were inoculated
in 1 ml of MH broth for further incubation at 37°C for 3
h. The cell suspensions of each of the colony were plated
on the MH plates containing 2.5 μg/ml chloramphenicol.
These plates were incubated at 29°C for 48 h. A few colo-
nies from each of the plates were used in colony PCR to
verify the integration of the plasmid into the chromo-
somal malT geneof A. pleuropneumoniae CM5. The primers
for the colony PCR were designed so that one primer
annealed inside the integrated plasmid and the other on
the nearby bacterial chromosomal DNA, thus verifying
both plasmid integration and orientation.
The colonies that had undergone plasmid integration at
the correct site were selected for the sucrose counter-selec-
tion. Selected individual colonies with an integrated plas-
mid were incubated with constant agitation in 1 ml of MH
broth at 37°C until the cultures were slightly turbid. A 1
ml volume of the counter-selection medium was then
added and each of the cultures was incubated for a further
5 h. A 50-μl cell suspension from each of the ten-fold
serial dilutions (100 to 107) of these cultures was then
plated onto the MH agar plates containing sucrose (10%)
and chloramphenicol (2.5 μg/ml). After incubation at
37°C for 48 h, colonies appearing on the plates were
patched onto two BHI agar plates; one containing chlo-
ramphenicol (2.5 μg/ml) and the other, ampicillin (100
μg/ml). Chloramphenicol-resistant, ampicillin-sensitive
colonies were screened for the second crossover by the
PCR using the primers that annealed to the regions of the
bacterial chromosome immediately flanking the malT
gene. The predicted disruption of the malT gene was con-
firmed by Southern blotting using the wild type malT gene
as a probe and by sequencing the PCR amplicon spanning
the cat gene insertion. The primers and plasmids used in
the construction of the malT mutant are given in Table 6.
Construction of the lamB knockout mutant
The construction of the lamB knockout mutant involved
the same approach as described for the construction of the
malT mutant. A central 379-bp region (bp 518 to bp 897)
of the lamB was replaced with the omlA-P driven cat gene
and the knockout mutation was confirmed by sequencing
and Southern blotting. The primers and plasmids used in
the construction of lamB mutant are given in Table 7.
Growth of the mutants
A. pleuropneumoniae CM5, and its isogenic malT and lamB
mutants were grown in BHI at 37°C to monitor their
growth. The OD600 of each of the strains was measured
every hour from the lag to stationary phase of growth to
construct growth curves. For doubling time calculations,
culture aliquots were taken at 2, 3, and 4 h of incubation
and the number of CFUs was determined by the plating of
10-fold dilutions. The data were analyzed using one way
analysis of variance (ANOVA) and the means were com-
pared using Tukey's method.
The wild-type organism and the malT and lamB mutants
were also incubated in the BHI containing 0.5% (wt/vol)
acarbose and 0.5% (wt/vol) maltose to assess the effect of
acarbose on the growth of these strains. As the strains grew
slowly in the acarbose-containing BHI, their growth was
measured after 16 h of incubation at 37°C.
Survival of the mutants in serum
Individual colonies from the overnight cultures of A. pleu-
ropneumoniae CM5, the malT and lamB mutants, and E. coliBMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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DH5α, were incubated in 5 ml of BHI at 37°C for 2 h. A
1 ml volume of each of the cultures was centrifuged at
10,000 ×g for 2 min to pellet the cells before suspension
in 1 ml of pre-warmed PBS. One hundred μl of a 1:105
dilution of each culture was added to 900 μl of 100 and
55.5% fresh porcine serum (vol/vol in PBS). As a control,
100 μl of 1:105 dilution of each culture was also added to
900 μl of heat-inactivated porcine serum (inactivated by
heating at 65°C for 15 min). The number of CFU of each
culture was determined after the incubation of the cul-
tures at 37°C for 1 h. The number of the CFU surviving in
fresh serum was expressed as percent survival according to
the following equation:
The experiment was run in quadruplicate, and the per-
cent-survival data were divided by 2 before being con-
verted to arcsin values for the analysis using two-way
ANOVA. Means were compared by Tukey's Method.
Survival of the mutants in sodium chloride
A. pleuropneumoniae CM5, and the malT and lamB mutants
were grown to an OD600 of 0.7 in the BHI broth supple-
mented with 1% (wt/vol) maltose. Each of these cultures
was mixed with fresh BHI containing 4 M sodium chlo-
ride in equal proportions for a final concentration of 2 M
sodium chloride; cultures containing 1 and 0.5 M of the
salt were prepared by the same approach. The number of
CFU of each culture was calculated prior to the addition
of the salt-containing BHI and 3 h subsequent to the incu-
bation at 37°C in salt-containing medium. The experi-
ment was repeated four times, and the data obtained were
analyzed using ANOVA. Means were compared using
Tukey's Method.
Microarray experiments
The AppChip2 microarray chips used in this study, were
an evolved version of the AppChip1 chip, and like its
predecessor, was a part of the A. pleuropneumoniae 5b L20
genome sequencing project (NRC-IBS, Ottawa, Canada).
For the construction of AppChip2, open-reading-frame
(ORF) PCR fragments of 160-nucleotide length and above
were spotted in duplicate on the microarray slides. The
spots represent 2033 ORFs, covering 95% of the total
ORFS, from the complete genome sequence of the organ-
ism. Spotted sheared genomic DNA from A. pleuropneumo-
niae L20 and porcine DNA were used as controls http://
ibs-isb.nrc-cnrc.gc.ca/glycobiology/appchips_e.html. Fur-
ther details concerning chip production are described
elsewhere [36].
Based on the strain (the wild-type organism or the malT
mutant) and the incubation medium (BHI or BALF), the
microarray experiments involved three types of hybridiza-
tions: (1) Cy3-labeled cDNA from the BHI-incubated
wild-type organism vs. Cy5-labeled cDNA from the BALF-
incubated wild-type organism (2) Cy3-labeled cDNA
from the BHI-incubated wild-type organism vs. Cy5-
labeled cDNA from the BALF-incubated malT mutant, and
(3) Cy3-labeled cDNA from the BHI-incubated wild-type
organism vs. Cy5-labeled cDNA from BHI-incubated malT
mutant. Four replications, including dye-swaps, were car-
ried out for each type of hybridization.
cDNA was synthesized in the presence of amino-allyl-
dUTP (Sigma-Aldrich, St. Louis MO, US), random
octamer primers (Biocorps, Montreal, QC, Canada),
SuperScript II transcriptase (Invitrogen, Carlsbad, CA,
US), and the RNA (15 μg per reaction) obtained from the
BALF- and BHI-incubated organisms, according to the
method described by Carrillo et al. [37]. Labeling of the
cDNA was carried out indirectly with one of the mono-
functional NHS-ester dyes Cy3 or Cy5 (GE Healthcare,
Buckinghamshire, UK), which binds to the amino-allyl-
dUTP of the cDNA. The dye labeling efficiency of cDNA
was determined spectrophotometrically. The data were
submitted to the Gene Expression Omnibus (GEO:
GSE13006).
Microarray data analysis
Microarray image and data analysis was carried out using
the TM4 Suite of software [38] for microarray analysis, (J.
Craig Venter Institute, JCVI, USA) as described elsewhere
[36]. Briefly, images were analyzed with Spotfinder
v3.1.1. The final intensity of each spot was obtained by
subtracting the background intensity from the integral
spot intensity (the sum of the intensities of all the spot
pixels excluding the saturated ones). The spots with inten-
sities less than one standard deviation above their spot
background intensities were eliminated from the down-
stream analysis, as were the ones with total intensity less
than 10000. Replicate spots were analyzed subsequent to
the normalization of the data using the LOWESS (locally
weighted linear regression) algorithm. The genes that
were thus represented by good quality spots (defined by a
score assigned by the software based on the number of
unsaturated pixels, shape, and signal to noise ratio of the
spot) on a minimum of two replicate slides were consid-
ered for the downstream analysis using SAM (significance
analysis of microarray) to identify the differentially
expressed genes. The differentially expressed genes were
classified depending upon their biological roles into vari-
ous functional categories according to the JCVIs Compre-
hensive Microbial Resources (CMR) database.
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Quantitative real-time PCR
The parameters of RNA capacity, optimum primer con-
centration, and the gene dynamic ranges were determined
before carrying out the real-time PCR for the relative
quantification of the target gene expression. As an endog-
enous control, the level of prolyl-tRNA-synthetase gene
(syp) expression was used to normalize the target gene
expression levels, since this gene exhibited the least varia-
tion in expression across various conditions in both the
microarray and real-time PCR experiments. In the quanti-
tative real-time PCR experiments, three independent bio-
logical replicates were tested in triplicate. Calculation of
the relative quantification of the target genes was done
using the Comparative CT (ΔΔCT) method [39]. The pro-
tocol of the PCR is given as described below:
Each 20-μl PCR reaction mixture contained 2 × Power
SYBR Green PCR Master Mix (Applied Biosystems, Street-
sville), 100 nM of each of forward and reverse primer, and
5 μl of template cDNA. Synthesis of the template cDNA
was carried out in a 20-μl reaction mixture containing 500
ng RNA, using a High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems), which contains random
primers for the synthesis of cDNA. The real-time PCR ther-
mal profile included the heat-activation of AmpliTaq
Gold DNA Polymerase at 95°C for 10 min, 40 cycles of
denaturation at 95°C for 15 s, and primer annealing and
extension at 60°C for 1 min. The PCR reactions were car-
ried out in 96-well plates using a StepOnePlus thermocy-
cler (Applied Biosystems, Streetsville, ON, Canada). The
primers used in the real-time PCR are given in Table 10.
List of abbreviations
BALF: bronchoalveolar lavage fluid; BHI: Brain Heart
Infusion; CFU: colony forming unit(s); NaCl: sodium
chloride; NAD: β-nicotinamide adenine dinucleotide;
ORF: Open Reading Frame; PAG: polyacrylamide gel;
PCR: polymerase chain reaction; RT-PCR DD: reverse-
transcription PCR differential display; vol: volume, wt:
weight.
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Table 10: Oligonucleotide primers used in the real-time PCR
Gene Forward primer Reverse primer
dmsA ATGTTGCCGGACAAGCACAAGATG TCTCAATGGACAACGGCTACCACA
dmsB AACAGGCATCGATTGCACCGTTAC ACTTGGACGTGCGTGTTTATTGGC
napB GCGCATGGCAACCTAAACATTGGT TACAGGCTTTGCAGTAGCGGAAAC
napD TCGGCTAAAGCAAGCTGTCTGTCA TAGCGCAAGTGAAAGCGGACATTC
napF ACAACCGTCTCCGCAACTTCTACA TTGGCTACAACGGAAGAAGCATGG
ilvH GAAAGTTTAACCGTTGCGCCGACT ACGTTCAATATGCTCGGTAGGGCT
pgaA GGGAACCGGTGTGAATGCAATGAA TGTTGGAACGTTTGTGAAGACGCC
pgaC ATCGTTGCGTTACACCAAGCGAAC ACCGACATACTTGCCTCTTGCGAT
apxIVA TTGGACTTCACCTGCAAACATGCC CGGGCAAATATTCCAAAGCGCAGA
relA TCGGACAGTTGAAGTGGGAAT TGCAAGGCGATTACTCGGTAA
syp AAGAAACGCCGAATGATGCACAGG ACACCTCGATAGCACCACCTTTGT
lamB CTGCTAAAGAGAGTTTACCGATGCCA TGCAACATTACGGGCAGGTAAACG
malK GCGTGTTGCAATTGGACGTACCTT CATGGCTTCGATTTGGTCATGCGT
malM AGCGACACCGTCAAAGACAGAACT CCAACGTTTGGCTAAATGTGCGGA
malT TCCTTGATGAGCTTTCGACCCACA TAAACCGAGCACCTGCCATTCTCT
malP ACGCTTAGCCGCCTGCTATTTAGA CACGCATCGCCTTCTTCATGTTGT
malQ ATGCCTATCGGCCTTTACCGTGAT ACCGACAGAGGCATCTAGCACAAA
malE AACCGATGAAGGACTCACAACCGT TTTCCGCATTCGCCATAGTTGCTG
malF TGCCGTTAATGATTGCCAGCTTCG GCAGCCGCTAAACCAAAGTCTTGT
malG AGTGTTACTCATGCGGACGGAAGT GCATACGCAGCAGTGGTTGAAAGTBMC Microbiology 2009, 9:195 http://www.biomedcentral.com/1471-2180/9/195
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